Lymphocyte activation and correlation with IMPDH activity under therapy with mycophenolate mofetil

Clinica Chimica Acta

Volumn 394, Issue 1-2, 2008, Pages 67-71

  Devyatko, Elena ^a   Dunkler, Daniela ^a   Bohdjalian, Arthur ^a   Zuckermann, Andreas ^a   Grimm, Michael ^a   Muehlbacher, Ferdinand ^a   Weigel, Guenter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Heart transplantation; Lymphocyte activation; Mycophenolate mofetil

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; INOSINATE DEHYDROGENASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; ARTICLE; CARDIAC GRAFT REJECTION; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; ENZYME ACTIVITY; FEMALE; HEART TRANSPLANTATION; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MONOCYTE; MONONUCLEAR CELL; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; FEMALE; HEART TRANSPLANTATION; HUMANS; IMP DEHYDROGENASE; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID;

EID: 44649111145     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.04.006     Document Type: Article

References (26)

1. Allison A.C., and Eugui E.M. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47 (2000) 85-118
2. Wu J.C. The mechanism of action of mycophenolate mofetil. Perspect Drug Discovery Design 2 (1994) 185-204
3. Ransom J.T. Mechanism of action of mycophenolate mofetil. Ther Drug Monit 17 (1995) 681-684
4. Sanquer S., Breil M., Baron C., Dhamane D., Astier A., and Lang P. Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil. Clin Pharmacol Ther 65 (1999) 640-648
5. Weigel G., Griesmacher A., Zuckermann A.O., Laufer G., and Mueller M.M. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients. Clin Pharmacol Ther 69 (2001) 137-144
6. Devyatko E., Zuckermann A., Bohdjalian A., et al. Activation of the purine salvage pathway in mononuclear cells of cardiac recipients treated with mycophenolate mofetil. Transplantation 82 (2006) 113-118
7. Seebacher G., Weigel G., Wolner E., et al. A simple and cost saving HPLC method for the determination of mycophenolic acid and its glucuronidated metabolite in human plasma after heart transplantation. Clin Chem Lab Med 37 (1999) 409-415
8. Daxecker H., Raab M., and Mueller M.M. Influence of mycophenolic acid on inosine 5′-monophosphate dehydrogenase activity in human peripheral blood mononuclear cells. Clin Chim Acta 318 (2002) 71-77
9. Bland J.M., and Altmann D.G. Calculating correlation coefficient with repeated observations. Part 1: correlation with subjects. BMJ 310 (1995) 446
10. Barten M.J., Dhein S., Chang H., et al. Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood. J Immunol Methods 283 (2003) 99-114
11. Quéméneur L., Flacher M., Gerland L.M., Ffrench M., Revillard J.P., and Bonnefoy-Berard N. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis. J Immunol 169 (2002) 2747-2755
12. Hutchinson P., Jose M., Atkins R.C., and Holdsworth S.R. Ex vivo lymphocyte proliferative function is severely inhibited in renal transplant patients on mycophenolate mofetil treatment. Transpl Immunol 13 (2004) 55-61
13. Gummert J.F., Barten M.J., Sherwood S.W., van Gelder T., and Morris R.E. Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics. J Pharmacol Exp Ther 291 (1999) 1100-1112
14. Gummert J.F., Barten M.J., van Gelder T., Billingham M.E., and Morris R.E. Pharmacodynamics of mycophenolic acid in heart allograft recipients: correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology. Transplantation 70 (2000) 1038-1049
15. Weigel G., Griesmacher A., Karimi A., Zuckermann A.O., Grimm M., and Mueller M.M. Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipients. J Heart Lung Transplant 21 (2002) 1074-1079
16. François M., Büchler M., Halimi J.M., et al. Lymphocyte subsets in renal transplant recipients treated with mycophenolate mofetil. Transplant Proc 32 (2000) 2781-2782
17. Meloni F., Morosini M., Solari N., et al. Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors. Int Immunopharmacol 6 (2006) 2002-2010
18. Lippert E., Jacques Y., and Hermouet S. Positive regulation of human T cell activation by Gi2 proteins and interleukin-8. J Leukoc Biol 67 (2000) 742-748
19. Gregori S., Casorati M., Amuchastegui S., Smiroldo S., Davalli A.M., and Adorini L. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 167 (2001) 1945-1953
20. Tian L., Lu L., Yuan Z., Lamb J.R., and Tam P.K. Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery. Transplantation 77 (2004) 183-189
21. Zeiser R., Nguyen V.H., Beilhack A., et al. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 108 (2006) 390-399
22. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 (2003) 330-336
23. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
24. Lim D., Joe I., Park Y., et al. Effect of immunosuppressants on the expansion and function of naturally occurring regulatory T cells. Transpl Immunol 18 (2007) 94-100
25. Kamar N., Glander P., Nolting J., et al. Effect of mycophenolate mofetil monotherapy on T-cell functions and inosine monophosphate dehydrogenase activity in patients undergoing a kidney transplantation. Transplant Proc 38 (2006) 2292-2294
26. Vacher-Coponat H., Brunet C., Moal V., et al. Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine. Transplantation 82 (2006) 558-566